Entrada Therapeutics, Inc. ($TRDA)
Filing Information
| Accession Number | 0001873392-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
160,261
Total Value
$249,241.35
P&L
+inf% (+$1,572,090.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & COO | Common Stock | โ | Mar 1, 2026 | Grant/Award | 55,800 | $0.00 | $0.00 | 234,859 | Direct | โ | View Details | |
President & COO | Common Stock | โ | Mar 2, 2026 | Tax Withholding | 7,223 | $11.66 | $84,205.01 | 227,636 | Direct | โ | View Details | |
President & COO | Common Stock | โ | Mar 3, 2026 | Tax Withholding | 14,038 | $11.76 | $165,036.34 | 213,598 | Direct | โ | View Details | |
President & COO | Stock Option (Right to Buy) | Derivative | Mar 1, 2026 | Grant/Award | 83,200 | $0.00 | $0.00 | 83,200 | Direct | โ | View Details |